Teva announces launch of first-to-market generic version of narcan® (naloxone hydrochloride nasal spray), in the u.s.

Tel aviv, israel & parsippany, n.j.--(business wire)--teva pharmaceuticals, a u.s. affiliate of teva pharmaceutical industries ltd. (nyse and tase: teva), today announced the launch of a first-to-market generic version of narcan®1 (naloxone hydrochloride nasal spray), in the united states. naloxone hydrochloride nasal spray is a prescription medicine used for the treatment of an opioid emergency such as an overdose or a possible opioid overdose with signs of breathing problems and severe sleepi
TEVA Ratings Summary
TEVA Quant Ranking